跳至主要内容
临床试验/IRCT20231123060147N1
IRCT20231123060147N1招募中3 期

Comparison of therapeutic effects and monotherapy with lacosamide versus carbamazepine in children with newly diagnosed epilepsy

Mazandaran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 years 至 16 years(—)
性别
All

入选标准

  • Children aged between 4 and 16 years with newly diagnosed epilepsy

排除标准

  • History of liver disease and history of heart disease
  • Receiving antiepileptic medication for more than 48 hours during the last three months
  • Patients with any neurodegenerative or neurometabolic disease
  • causing an allergic reaction
  • Dissatisfaction of the patient and the patient's parents
  • Patients with a history of bone marrow suppression

研究者

相似试验